Annual CFO
$87.00 K
+$229.90 K+160.88%
December 1, 2023
Summary
- As of March 10, 2025, ASBP annual cash flow from operations is $87.00 thousand, with the most recent change of +$229.90 thousand (+160.88%) on December 1, 2023.
- During the last 3 years, ASBP annual CFO has risen by +$229.90 thousand (+160.88%).
Performance
ASBP Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFO
-$744.80 K
-$533.80 K-252.99%
September 1, 2024
Summary
- As of March 10, 2025, ASBP quarterly cash flow from operations is -$744.80 thousand, with the most recent change of -$533.80 thousand (-252.99%) on September 1, 2024.
- Over the past year, ASBP quarterly CFO has dropped by -$533.80 thousand (-252.99%).
Performance
ASBP Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
-$955.80 K
-$490.50 K-105.42%
September 1, 2024
Summary
- As of March 10, 2025, ASBP TTM cash flow from operations is -$955.80 thousand, with the most recent change of -$490.50 thousand (-105.42%) on September 1, 2024.
- Over the past year, ASBP TTM CFO has dropped by -$490.50 thousand (-105.42%).
Performance
ASBP TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ASBP Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +160.9% | -253.0% | -105.4% |
| 3 y3 years | +160.9% | -253.0% | -105.4% |
| 5 y5 years | +160.9% | -253.0% | -105.4% |
ASBP Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -264.3% | -1651.7% | at low | -2091.3% | at low |
| 5 y | 5-year | at high | -264.3% | -1651.7% | at low | -2091.3% | at low |
| alltime | all time | at high | -264.3% | -1651.7% | at low | -2091.3% | at low |
Aspire BioPharma Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$744.80 K(+253.0%) | -$955.80 K(+105.4%) |
| Jun 2024 | - | -$211.00 K(-17.0%) | -$465.30 K(+125.5%) |
| Dec 2023 | $87.00 K | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$254.30 K(-629.8%) | -$206.30 K(-529.8%) |
| Jun 2023 | - | $48.00 K | $48.00 K |
| Dec 2022 | -$142.90 K | - | - |
FAQ
- What is Aspire BioPharma annual cash flow from operations?
- What is the all time high annual CFO for Aspire BioPharma?
- What is Aspire BioPharma annual CFO year-on-year change?
- What is Aspire BioPharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for Aspire BioPharma?
- What is Aspire BioPharma quarterly CFO year-on-year change?
- What is Aspire BioPharma TTM cash flow from operations?
- What is the all time high TTM CFO for Aspire BioPharma?
- What is Aspire BioPharma TTM CFO year-on-year change?
What is Aspire BioPharma annual cash flow from operations?
The current annual CFO of ASBP is $87.00 K
What is the all time high annual CFO for Aspire BioPharma?
Aspire BioPharma all-time high annual cash flow from operations is $87.00 K
What is Aspire BioPharma annual CFO year-on-year change?
Over the past year, ASBP annual cash flow from operations has changed by +$229.90 K (+160.88%)
What is Aspire BioPharma quarterly cash flow from operations?
The current quarterly CFO of ASBP is -$744.80 K
What is the all time high quarterly CFO for Aspire BioPharma?
Aspire BioPharma all-time high quarterly cash flow from operations is $48.00 K
What is Aspire BioPharma quarterly CFO year-on-year change?
Over the past year, ASBP quarterly cash flow from operations has changed by -$533.80 K (-252.99%)
What is Aspire BioPharma TTM cash flow from operations?
The current TTM CFO of ASBP is -$955.80 K
What is the all time high TTM CFO for Aspire BioPharma?
Aspire BioPharma all-time high TTM cash flow from operations is $48.00 K
What is Aspire BioPharma TTM CFO year-on-year change?
Over the past year, ASBP TTM cash flow from operations has changed by -$490.50 K (-105.42%)